IRIS
CORTI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.618
NA - Nord America 2.167
EU - Europa 1.848
SA - Sud America 1.482
AF - Africa 100
OC - Oceania 2
Totale 10.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.074
SG - Singapore 2.046
BR - Brasile 1.241
CN - Cina 1.192
HK - Hong Kong 706
SE - Svezia 686
VN - Vietnam 364
RO - Romania 268
RU - Federazione Russa 241
IT - Italia 178
DE - Germania 159
AR - Argentina 97
FI - Finlandia 76
IN - India 72
GB - Regno Unito 65
EC - Ecuador 49
BD - Bangladesh 44
IE - Irlanda 43
ID - Indonesia 40
AT - Austria 37
MX - Messico 36
ZA - Sudafrica 35
CA - Canada 32
CO - Colombia 29
JP - Giappone 27
PY - Paraguay 24
PL - Polonia 21
IQ - Iraq 20
NL - Olanda 20
FR - Francia 19
TR - Turchia 17
MA - Marocco 14
PE - Perù 12
EG - Egitto 11
VE - Venezuela 11
ES - Italia 10
PK - Pakistan 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
UY - Uruguay 9
IR - Iran 8
KE - Kenya 8
LT - Lituania 8
NP - Nepal 7
TN - Tunisia 7
UA - Ucraina 7
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
GE - Georgia 5
JO - Giordania 5
SA - Arabia Saudita 5
DZ - Algeria 4
ET - Etiopia 4
KR - Corea 4
NG - Nigeria 4
SN - Senegal 4
AL - Albania 3
BB - Barbados 3
CR - Costa Rica 3
GA - Gabon 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
TT - Trinidad e Tobago 3
AU - Australia 2
BN - Brunei Darussalam 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
PA - Panama 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
LK - Sri Lanka 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 10.217
Salva come PNG Salva come JPEG
Città #
Singapore 792
Hong Kong 701
Dallas 509
Shanghai 297
Hefei 287
Lawrence 266
Princeton 266
Ashburn 207
Ho Chi Minh City 138
São Paulo 114
Beijing 106
New York 81
Milan 67
Los Angeles 63
Hanoi 60
Helsinki 59
Moscow 53
Rio de Janeiro 42
Dublin 40
Nuremberg 35
Pune 34
Guangzhou 25
Tokyo 24
Boardman 23
The Dalles 23
Montreal 20
Curitiba 19
Da Nang 19
Munich 19
Brasília 18
Campinas 18
Denver 18
Quito 18
Santa Clara 18
Columbus 17
Warsaw 17
Guarulhos 16
Vienna 16
Belo Horizonte 15
Johannesburg 15
Stockholm 15
Chennai 14
Dhaka 14
Haiphong 14
London 14
Frankfurt am Main 13
Goiânia 13
Hải Dương 13
Salvador 13
Turku 13
Brooklyn 12
Hangzhou 12
Mexico City 12
Poplar 12
Porto Alegre 12
Rome 12
Santo André 12
Seattle 12
Asunción 11
Chicago 11
Jakarta 11
Manaus 11
Phoenix 11
San Francisco 11
Shenzhen 11
Fortaleza 10
Guayaquil 10
Xi'an 10
Atlanta 9
Biên Hòa 9
Boston 9
Recife 9
Ribeirão Preto 9
Sorocaba 9
Tashkent 9
Thái Bình 9
Cape Town 8
Cesano Boscone 8
Houston 8
Lima 8
Manchester 8
Montevideo 8
Orem 8
Thái Nguyên 8
Washington 8
Wuxi 8
Baghdad 7
Can Tho 7
Duque de Caxias 7
Ha Long 7
Ipatinga 7
Joinville 7
Juiz de Fora 7
Leer 7
Medellín 7
Resistencia 7
São Bernardo do Campo 7
Aparecida de Goiânia 6
Belém 6
Brescia 6
Totale 5.161
Salva come PNG Salva come JPEG
Nome #
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 342
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 91
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 88
A pilot phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma 83
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 79
Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth 76
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 75
A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins 74
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 72
Chromogranin A plasma levels predict mortality in COVID-19 69
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 68
Altered Chromogranin A Circulating Levels in Meniere’s Disease 68
A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on α5β1-targeted gold nanorods 62
Aminopeptidase N (CD13)-positive bone marrow-derived cells induce angiogenesis and tumor growth: A potential non-malignant immune cell target against cancer 62
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging 62
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 62
A rapid method for monitoring DNA labelling reactions with haptens. 59
A receptor-antibody sandwich assay for teicoplanin. 59
A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8 59
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 59
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 57
[Activation and role of the tumor necrosis factor-alpha in congestive heart failure]. FT Attivazione e ruolo del fattore di necrosi tumorale alfa nello scompenso cardiaco congestizio. 56
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 56
A new chromogranin A-dependent angiogenic switch activated by thrombin 53
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 53
Chromogranin-A production and fragmentation in patients with Takayasu arteritis. 52
A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator. 51
Production and characterisation of human recombinant single chain urokinase-type plasminogen activator from mouse cells 50
A novel aminopeptidase N/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins 50
A new method for rapid and simple pregnancy detection using gold-labelled antibodies 47
Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models 47
Agents regulating vascular permeability 47
Affinity enhancement of complementary peptide recognition 47
Ways to improve tumor uptake and penetration of drugs into solid tumors 46
Won't you come on in? How to favor lymphocyte infiltration in tumors 45
Tumor necrosis factor-α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the successful treatment of patients with infliximab 45
Catestatin inhibits obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production, leading to improved insulin sensitivity 45
Spatiotemporal regulation of tumor angiogenesis by circulating chromogranin a cleavage and neuropilin-1 engagement 45
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy 44
TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens 44
Isoaspartate-glycine-arginine: A new tumor vasculature-targeting motif 44
Oxidative stress biomarkers and chromogranin A in uremic patients: Effects of dialytic treatment 44
Tumor necrosis factor in heart failure 44
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 44
Receptor-antibody sandwich assay. 44
Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study 44
Quantification of Chromogranin A and Its Fragments in Biological Fluids 43
Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer 43
The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells 43
Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides 43
Anti-urokinase monoclonal antibody, matrix bearing it, test method, biochemical test kits which use it. 43
Identification of an epitope of tumor-necrosis-factor (TNF) receptor-type-1 (p55) recognized by a TNF-alpha-antagonist monoclonal-antibody 43
Breaching the blood–brain tumor barrier for tumor therapy 43
Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy 42
Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications, and alternative roads 42
Liposome-Mediated Therapy of Neuroblastoma 41
Autocrine saturation of pro-urokinase receptors on human A431cells 41
Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion 41
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype 41
Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action 40
Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. 40
Cytokine conjugates (IL-12 –peptide conjugates) 40
Anti-idiotype monoclonal antibody directed against anti-TNF antibodies 40
Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism 40
Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to αvβ3 without Promoting Integrin Allosteric Activation 40
Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting 40
Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching 39
Chromogranin A Regulates Tumor Self-Seeding and Dissemination 39
Tumour necrosis factor: Strategies for improving the therapeutic index 39
Tumor targeting with biotinylated tumor necrosis factor alpha: Structure-activity relationships and mechanism of action on avidin pretargeted tumor cells 39
STRUCTURAL BASIS FOR THE INTERATION OF ISODGR WITH RGD-BINDING SITE OF αvβ3 INTEGRIN 39
NGR-Tagged Nano-Gold: a new CD13-selective carrier for cytokine delivery to tumors 39
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours 39
Tumor Necrosis Factor: methods and protocols 39
Chromogranin A and the Tumor Microenvironment 39
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms 39
A Pilot Study on Continuous Infusion of 4% Albumin in Critically Ill Patients: Impact on Nosocomial Infection via a Reduction Mechanism for Oxidized Substrates 39
Oxidation-induced structural changes of ceruloplasmin foster NGR-motifs deamidation that promote integrin binding and signaling 39
Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α 38
Mode of interaction between tumor-necrosis-factor-alpha and a monoclonal-antibody expressing a recurrent idiotype 38
Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA(1-64)) in the rat heart 38
Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha 38
Development of an immunoassay for the derived-peptide of chromogranin A, Vasostatin-I (1-76): assessment of severity in patients with sepsis. 38
Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A 38
Solid-phase receptor assay for antibiotics of the vancomycin class. 38
T cells redirected to a minor histocompatibility antigen instruct intratumoral TNFα expression and empower adoptive cell therapy for solid tumors 38
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity 38
The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1 38
The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key? 37
Structure-activity relationships of chromogranin A in cell adhesion - Identification of an adhesion site for fibroblasts and smooth muscle cells 37
Commentary: Granins, Secretory Granule Biogenesis, and Transport 37
Oligomeric Tumor-necrosis factor alpha slowly converts into inactive forms at bioactive levels 37
Association between preoperative Vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET) 37
Contrast enhanced photoacoustic detection of fibrillar collagen in the near infrared region-I 36
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells 36
Identification of differentially glycosylated forms of the soluble p75 tumor-necrosis-factor (TNF) receptor in human urine 36
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas 36
Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse 36
Kinetic-analysis of TNF-alpha oligomer monomer transition by surface-plasmon resonance and immunochemical method 36
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 36
Totale 5.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 4 0 0 0 0 0
2021/2022111 0 0 0 70 0 7 7 5 2 2 1 17
2022/20231.296 604 245 115 3 2 138 42 67 64 5 5 6
2023/2024417 5 8 62 36 26 88 24 33 0 18 37 80
2024/20253.632 461 37 54 101 80 265 744 277 649 504 226 234
2025/20264.816 698 934 771 1.635 678 100 0 0 0 0 0 0
Totale 10.358